MedTrace Logo

Feasibility and Acceptability Study of ACUAWARE

NCT06145997 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2025-03-24

No results posted yet for this study

Summary

This study aims to gather preliminary feasibility and acceptability data to justify a subsequent trial that would fill a gap in knowledge regarding acupuncture therapy (AT) effects on interoceptive awareness (IA) among those with chronic pain.

Conditions

Interventions

OTHER

Acupuncture therapy

Acupuncture therapy (AT) is delivered by Licensed Acupuncturists (LAcs). Treatment plans are determined according to each patient's presentation and resulting traditional East Asian medicine (TEAM) differential diagnosis. TEAM therapeutics include AT, Chinese herbal medicine (CHM), Kampo herbal medicine, gua sha, tui na, cupping and lifestyle advice. All TEAM therapeutics are allowed in this study because it is a pragmatic, effectiveness study.

Sponsors & Collaborators

Principal Investigators

  • Lisa J Taylor-Swanson, PHD · University of Utah College of Nursing

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2024-10-15
Completion
2024-10-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06145997 on ClinicalTrials.gov